Targeted drug delivery aims to direct therapeutic agents specifically to diseased tissues, thereby reducing systemic side effects. Catalysts can be employed to achieve this by attaching to nanoparticles or other delivery systems that release the drug in response to specific biological signals or environmental conditions present at the disease site.
